Selling a life insurance policy with lymphoma
Lymphoma diagnoses can vary significantly, making individualized policy reviews especially important.
At a glance
- Typical payoutVaries by case
- Best fitType & progression reviewed
- Tax treatmentOften tax-free under §101(g)
- Timeline30-60 days to funds
- EligibilityPolicy ≥ $100K, 2+ years old
What patients with lymphoma should know
Lymphoma includes many different types and can respond very differently to treatment, so settlement eligibility and value are reviewed case by case rather than by a single rule. For patients facing ongoing treatment, selling an existing policy can turn an asset that might otherwise lapse into cash you can use now.
When reviewing a lymphoma case, buyers typically look at the type of lymphoma, current treatment status, disease progression, and overall prognosis. Advanced or aggressive cases may qualify for a viatical settlement under IRS §101(g), which is generally tax-free at the federal level when a physician certifies the diagnosis.
How payout ranges work
Because lymphoma outcomes vary so widely, offers are highly individual — there’s no single percentage that fits every case. The amount depends on diagnosis, stage, prognosis, age, policy type, and carrier. A free, licensed review gives you a specific range, and patients who qualify typically receive substantially more than the policy’s cash surrender value, often delivered within 30-60 days of acceptance.
What we’d recommend asking
- What’s the difference between a life settlement and a viatical settlement for my diagnosis?
- How will this affect my Medicaid eligibility?
- What documentation does the buyer need from my oncologist?
- Is there a rescission window if I change my mind?
- Are there better alternatives (policy loan, accelerated death benefit rider)?
Related resources
See what your policy is worth.
Thirty seconds to find out. No medical records, no credit check, no cost.